219 related articles for article (PubMed ID: 37656283)
1. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
[No Abstract] [Full Text] [Related]
2. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
[TBL] [Abstract][Full Text] [Related]
3. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Gillies D; Leach MJ; Perez Algorta G
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007986. PubMed ID: 37058600
[TBL] [Abstract][Full Text] [Related]
6. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
7. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.
Puri BK; Martins JG
Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):179-89. PubMed ID: 24560325
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis.
Bloch MH; Qawasmi A
J Am Acad Child Adolesc Psychiatry; 2011 Oct; 50(10):991-1000. PubMed ID: 21961774
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
Kelaiditis CF; Gibson EL; Dyall SC
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids for the treatment of dementia.
Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
Wu Q; Zhou T; Ma L; Yuan D; Peng Y
Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
Parletta N; Niyonsenga T; Duff J
PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
16. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.
Checa-Ros A; Haro-García A; Seiquer I; Molina-Carballo A; Uberos-Fernández J; Muñoz-Hoyos A
Minerva Pediatr; 2019 Aug; 71(4):313-325. PubMed ID: 30419741
[TBL] [Abstract][Full Text] [Related]
17. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
[TBL] [Abstract][Full Text] [Related]
18. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
Lin PY; Su KP
J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
[TBL] [Abstract][Full Text] [Related]
19. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of omega-3 PUFAs in depression: A meta-analysis.
Liao Y; Xie B; Zhang H; He Q; Guo L; Subramanieapillai M; Fan B; Lu C; McIntyre RS
Transl Psychiatry; 2019 Aug; 9(1):190. PubMed ID: 31383846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
